NeuroBo Pharmaceuticals announced the completion of enrollment for its Phase 1 clinical trial of DA-1726, with 45 participants enrolled across 5 cohorts for obesity treatment.
AI Assistant
METAVIA INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.